Hide
Menu
Menu
Read the latest issue

The Onco’Zine Brief

Peter Hofland, Ph.D
Peter Hofland, Ph.D

Presenter

Peter Hofland (PhD) is a highly motivated and experienced (medical/life sciences/pharma) communication consultant working for Sunvalley Communication and InPress Media Group. With a PhD in medical science and various postdoctoral training/certificates, Hofland has more than 18 years medical/pharmaceutical experience. He is Publisher/Executive Editor of Onco'Zine and ADC Review/Journal of Antibody-drug Conjugates.   Co-presenter Sonia Portillo is an associate editor of ADC Review/Journal of Antibo

The Onco’Zine Brief is an interview and discussion program presented by Peter Hofland, Ph.D and Sonia Portillo, covering a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.

The Onco’Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends.

The show invites scientists, researchers, medical experts, key opinion leaders, authors, caregivers, cancer patients and survivors to share the latest information about the new developments in the treatment of cancer.

Production team:

The Onco’Zine Brief is produced for Sunvalley Communication, LLC by Peter Hofland, Ph.D, Sonia Portillo, Eric Rosenthal, Evan Wendt, David Caylor and Shaun Mehr and distributed by InPress Media Group, LLC

Episodes

The Onco’Zine Brief

Peter Hofland talks with David M. Cognetti, MD, a Prof and Chair in the Department Head and Neck Surgery… about head and neck cancer and a novel treatment approach called Photoimmunotherapy

The Onco’Zine Brief

Dr. Heery, MD, a medical oncologist with expertise in the translational and clinical development of immunotherapies and with Dr. Verstovsek about the developments in treatment of myeloproliferative neoplasm

The Onco’Zine Brief

The developments in the treatment of Multiple Myeloma - Peter talk to Dr. Thomas Martin and Dr Monica Soni about their research and the impact the outcomes from these studies may have

The Onco’Zine Brief

Peter Hofland talks with Dr. Matthias Bucerius, Vice President and General Manager at Merck KGaa, who is developing and manufacturing a variety of products, including antibody-drug conjugates

The Onco’Zine Brief

In this, the 100th episode! - How mismatched unrelated Bone-Marrow Donors may help erase the gap in donor availability and deliver allogeneic hematopoietic cell transplantation to patient…

The Onco’Zine Brief

Peter talks with Susanna F. Greer, Ph.D. the CSO of the V Foundation who works with the V Foundation’s Scientific Advisory Committee to steer funding to the most promising research opportunities

TODAY’S SCHEDULE